Krystexxa (Horizon Pharma Inc.)
Welcome to the PulseAid listing for the Krystexxa drug offered from Horizon Pharma Inc.. This Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Horizon Pharma Inc. |
NON-PROPRIETARY NAME: | pegloticase |
SUBSTANCE NAME: | PEGLOTICASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2010-09-14 |
END MARKETING DATE: | 0000-00-00 |
Krystexxa HUMAN PRESCRIPTION DRUG Details:
Item Description | Krystexxa from Horizon Pharma Inc. |
LABELER NAME: | Horizon Pharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8(mg/mL) |
START MARKETING DATE: | 2010-09-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75987-080_c8958f99-0e87-406d-97e0-1346139f32e8 |
PRODUCT NDC: | 75987-080 |
APPLICATION NUMBER: | BLA125293 |
Other PEGLOTICASE Pharmaceutical Manufacturers / Labelers: